Skip to main content
Daily Report

Daily Sepsis Research Analysis

05/10/2026
3 papers selected
11 analyzed

Analyzed 11 papers and selected 3 impactful papers.

Summary

Three studies advance sepsis research across mechanisms, monitoring, and precision phenotyping: a mechanistic study identifies a GATM–PDK4 axis that restores mitochondrial energetics in sepsis-induced AKI; a large ICU cohort shows cardiac index and LVEF are non-equivalent yet complementary prognostic markers; and longitudinal blood transcriptomics reveals a neutrophil-driven signature tracking severity and mortality.

Research Themes

  • Metabolic reprogramming and mitochondrial protection in sepsis-induced organ injury
  • Hemodynamic phenotyping and echocardiographic risk stratification in sepsis
  • Longitudinal transcriptomics for immune dynamics and mortality prediction in sepsis

Selected Articles

1. GATM alleviates sepsis-induced acute kidney injury via PDK4-mediated glycolytic reprogramming in renal tubular epithelial cells.

84Level VCase-control
Cellular and molecular life sciences : CMLS · 2026PMID: 42105097

Cross-dataset discovery and preclinical validation identify GATM as a protective regulator in S-AKI. GATM overexpression suppresses PDK4-driven glycolysis, lowers lactate, boosts ATP, and mitigates tubular and mitochondrial injury; PDK4 overexpression reverses these benefits, positioning the GATM–PDK4 axis as a targetable metabolic pathway.

Impact: This study reveals a novel metabolic checkpoint (GATM–PDK4) that restores proximal tubular energetics in sepsis, integrating in vivo, in vitro, and transcriptomic evidence with mechanistic rescue.

Clinical Implications: While preclinical, the GATM–PDK4 axis suggests therapeutic avenues such as PDK4 inhibition or GATM augmentation to prevent or treat sepsis-associated AKI by restoring mitochondrial function.

Key Findings

  • GATM was identified across four GEO datasets as a key downregulated gene in proximal tubule cells during S-AKI and LPS-stimulated HK-2 cells.
  • AAV-mediated GATM overexpression improved renal function, reduced KIM-1, IL-6, Caspase-3, and 4-HNE, and mitigated mitochondrial injury in LPS-induced S-AKI mice.
  • GATM overexpression downregulated PDK4, decreased glycolytic markers (p-PDHA, HK2, LDHA, GLUT1) and lactate, and increased ATP in HK-2 cells.
  • PDK4 overexpression abolished GATM’s protective effects, enhancing glycolysis, raising lactate, and reducing ATP, supporting a GATM→PDK4 pathway.

Methodological Strengths

  • Cross-cohort bioinformatic discovery followed by in vivo and in vitro validation
  • Mechanistic rescue experiment (PDK4 overexpression) supporting causality
  • Multimodal assessments (WB/IHC/IF, TEM, TUNEL, metabolic assays)

Limitations

  • LPS-induced S-AKI may not fully recapitulate polymicrobial sepsis
  • Overexpression models without complementary loss-of-function of GATM in vivo
  • Translational biomarkers and dosing strategies for PDK4/GATM modulation not evaluated

Future Directions: Validate GATM loss-of-function in diverse sepsis models (e.g., CLP), test PDK4 inhibitors as therapeutics, and develop translatable biomarker panels for patient stratification in S-AKI.

BACKGROUND: This study aimed to identify a key target gene in proximal tubule cells (PTCs) of sepsis-induced acute kidney injury (S-AKI) and elucidate the underlying mechanisms. METHODS: We screened and analyzed GEO datasets and identified a key gene, GATM, in S-AKI. An S-AKI mouse model was established via intraperitoneal injection of lipopolysaccharide (LPS), and HK-2 cells were used for in vitro experiments. The role of GATM was evaluated using adeno-associated virus (AAV)-mediated overexpression in mice and plasmid-mediated overexpression in HK-2 cells. To identify the downstream target genes of GATM, transcriptome sequencing was conducted. Pathological evaluation was performed using hematoxylin-eosin (HE) and periodic acid-Schiff (PAS) staining. Protein levels were determined by Western blotting (WB), immunohistochemistry (IHC), and immunofluorescence (IF) assays; Apoptosis was evaluated by TUNEL staining; Mitochondrial morphology and function were assessed by transmission electron microscopy (TEM), JC-1 and MitoSOX assays. Lactate concentration and cellular ATP levels were measured. RESULTS: Through analysis of four datasets (GSE151658, GSE247727, GSE220812, and GSE139061), GATM was identified as a key gene in PTCs during S-AKI. GATM expression was downregulated in both S-AKI mice and LPS-stimulated HK-2 cells. In vivo, GATM overexpression improved renal function, alleviated tubular damage, decreased the expression of KIM-1, IL-6, Caspase-3, and 4-HNE, and reduced mitochondrial injury. In vitro, HK-2 cell viability was enhanced, TUNEL-positive cells were reduced, and damaged mitochondria were decreased. Transcriptome sequencing revealed that the PDK4-mediated glycolysis pathway was a downstream target of GATM. GATM overexpression downregulated PDK4 expression, reduced glycolytic enzyme levels (p-PDHA, HK2, LDHA, GLUT1) and lactate, and increased ATP production. However, PDK4 overexpression in HK-2 cells abolished the protective effects of GATM, enhanced glycolysis, increased lactate levels, and reduced ATP production. CONCLUSION: GATM plays a protective role in S-AKI by inhibiting PDK4-mediated aerobic glycolysis, enhancing ATP production, and restoring energy metabolism and mitochondrial function in PTCs.

2. Comparing cardiac index and left ventricular ejection fraction in ICU patients with sepsis.

66Level IIICohort
Journal of critical care · 2026PMID: 42105488

In 1,731 septic ICU patients, cardiac index and LVEF showed only moderate correlation (r=0.51) and diverged particularly when abnormal. Both low and high values independently associated with higher 90-day mortality, and combining CI with LVEF yielded superior prognostic discrimination versus either metric alone.

Impact: This large, well-analyzed cohort clarifies the non-equivalence of CI and LVEF in septic hemodynamics and demonstrates that combining them materially improves mortality risk stratification.

Clinical Implications: Echocardiographic assessment in sepsis should report and interpret CI and LVEF together, with attention to discordance, to refine prognostication and guide hemodynamic management.

Key Findings

  • CI and LVEF were only moderately correlated (Spearman r=0.51; 95% CI 0.47–0.54).
  • Low and high CI had similar and high 90-day mortality (both 54%) versus normal CI (20%).
  • Low and high LVEF subgroups had 90-day mortality of 43% and 59% versus normal LVEF (23%).
  • Adjusted associations with 90-day mortality: low CI OR 2.6, high CI OR 3.4 (both p<0.001); low LVEF OR 1.6 (p=0.004), high LVEF OR 3.2 (p<0.001).
  • Combining CI with LVEF stratification significantly improved mortality discrimination.

Methodological Strengths

  • Large sample size with multivariable logistic regression
  • Prespecified subgrouping by low/normal/high phenotypes and 90-day outcome assessment

Limitations

  • Single-center retrospective design with potential residual confounding
  • Timing of echocardiography within 7 days may miss early dynamic changes

Future Directions: Prospective multicenter validation, integration with invasive hemodynamics and right ventricular metrics, and testing impact on management decisions and outcomes.

BACKGROUND: The optimal parameter to assess cardiovascular function in sepsis is currently unknown. We investigated whether echocardiography-derived cardiac index offers superior haemodynamic monitoring and prognostic value compared to left ventricular ejection fraction (LVEF) in ICU patients with sepsis. METHODS: We conducted a retrospective, single-centre cohort study in ICU patients with sepsis admitted between April 2016 and December 2021 that received a transthoracic echocardiogram (TTE) within seven days of sepsis onset. Correlation between CI and LVEF was assessed using the Spearman rank test. The 90-day mortality rates of normal, low and high CI and LVEF subgroups were compared. Multivariable logistic regression analysis was performed to determine the association of CI and LVEF phenotypes with mortality. RESULTS: 1731 patients were included and were aged 62 years (IQR 47-72), with 21% (n = 367) having septic shock. Ninety-day mortality was 32.5% (n = 561). Although CI and LVEF demonstrated moderate correlation (r = 0.51 (0.47-0.54), one-third of patients in a given CI subgroup were classified into a discordant LVEF subgroup. The 90-day mortality rates of low and high CI (54%, 54%) and low and high LVEF subgroups (43%, 59%) were broadly comparable and were higher than their normal CI (20%) and LVEF (23%) counterparts respectively. After regression analysis, low and high CI independently associated with mortality (OR 2.6 (1.8-3.7; p < 0.001), (OR 3.4 (2.7-4.4; p < 0.001), as did low and high LVEF subgroups (OR 1.6 (1.2-2.3; p = 0.004), OR 3.2 (2.4-4.3; p < 0.001). Stratifying CI subgroups into low, normal and high LVEF (and vice-versa) was associated with significantly different mortality rates. CONCLUSIONS: Although CI and LVEF were modestly correlated, this association weakened when either parameter was abnormal, highlighting their non-equivalence as haemodynamic parameters. While both markers exhibited comparable associations with mortality, their combination substantially improved prognostic accuracy.

3. Longitudinal blood transcriptome profiling reveals immune dynamics in sepsis.

63Level IIICohort
BMC infectious diseases · 2026PMID: 42106604

Serial whole-blood RNA-seq in 11 adults with sepsis/septic shock defined a neutrophil-dominant gene signature whose enrichment increased with severity and waned over time. External validation across bulk and single-cell datasets linked the signature to 28-day mortality, supporting its potential for dynamic risk stratification.

Impact: Despite small size, rigorous longitudinal design with external validation uncovers a biologically coherent, neutrophil-driven signature that tracks clinical severity and predicts mortality.

Clinical Implications: Longitudinal transcriptomic scoring may complement clinical tools to monitor evolving immune status and stratify risk; translation to streamlined assays (e.g., qPCR panels) is needed for bedside use.

Key Findings

  • PCA-derived PC1 separated samples by sepsis severity and sampling timepoints.
  • Top 50 PC1 genes formed three transcriptomic subgroups with distinct patterns.
  • Signature enrichment increased with severity, declined over days 1–7, and associated with 28-day mortality in multiple external cohorts.
  • Functional enrichment implicated neutrophil-associated pathways, supported by single-cell RNA-seq validation.

Methodological Strengths

  • Serial sampling with unbiased PCA to derive signatures
  • External validation across multiple bulk cohorts and single-cell datasets
  • Use of ssGSEA enrichment scores enabling cross-dataset comparison

Limitations

  • Small, single-center cohort (n=11) limits internal power
  • Limited timepoints (days 1, 3, 7) and no interventional testing
  • Potential platform and batch effects despite normalization

Future Directions: Scale to multicenter cohorts with pre-specified clinical endpoints, translate to targeted assays, and test signature-guided stratification in adaptive trials.

BACKGROUND: Sepsis is a life-threatening condition caused by a dysregulated host response to infection, with significant biological heterogeneity. Transcriptomic profiling offers insights into immune-related gene expression patterns that may inform patient stratification. This study aimed to identify transcriptomic signatures of sepsis or septic shock. METHOD: Eleven adult patients who presented to the emergency department with sepsis or septic shock were enrolled at a tertiary hospital in Korea. Serial whole-blood samples were collected on days 1, 3, and 7. RNA sequencing was performed using Illumina paired-end protocols. Principal component analysis (PCA) was performed on normalized transcriptomic data to derive a gene signature. Enrichment scores were calculated using single-sample gene set enrichment analysis and validated in external bulk and single-cell RNA-seq datasets. RESULTS: PCA identified first principal component (PC1) as the major axis of variation, separating samples by sepsis severity and timepoint. Clustering of the top 50 PC1 contributing genes identified three transcriptomic subgroups with distinct expression patterns. Enrichment scores for this gene set increased with severity and declined over time. In multiple external sepsis cohorts, enrichment scores showed consistent trends and were significantly associated with 28-day mortality. Functional analysis revealed predominant neutrophil-associated pathways, as further supported by external single-cell RNA-seq validation. CONCLUSIONS: We identified a neutrophil-driven transcriptomic signature associated with sepsis severity and temporal immune dynamics. These findings suggest that longitudinal transcriptomic profiling may provide additional insight into the evolving host immune response during sepsis.